ReviewLife (Basel, Switzerland)2026

Cardiometabolic 2.0: Redefining Cardiovascular Prevention Through SGLT-2 Inhibitors and GLP-1 Receptor Agonists.

Maria-Daniela Tanasescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.